Lung CT scan features at the diagnosis of IPA according to patient groups
| Sign . | Allogeneic HSCT (N = 23), no. (%) . | AL (N = 22), no. (%) . | Others* (N = 10), no. (%) . |
|---|---|---|---|
| Angioinvasive† | 3 (13) | 10 (45) | 1 (10) |
| Airway-invasive‡ | 10 (44) | 3 (14) | 2 (20) |
| Both angioinvasive and airway-invasive | 3 (13) | 2 (9) | 2 (20) |
| Neither angioinvasive nor airway-invasive§ | 7 (30) | 7 (32) | 5 (50) |
| Sign . | Allogeneic HSCT (N = 23), no. (%) . | AL (N = 22), no. (%) . | Others* (N = 10), no. (%) . |
|---|---|---|---|
| Angioinvasive† | 3 (13) | 10 (45) | 1 (10) |
| Airway-invasive‡ | 10 (44) | 3 (14) | 2 (20) |
| Both angioinvasive and airway-invasive | 3 (13) | 2 (9) | 2 (20) |
| Neither angioinvasive nor airway-invasive§ | 7 (30) | 7 (32) | 5 (50) |
Non-AL patients and no allogeneic HSCT (lymphoma, chronic lymphocytic leukemia, multiple myeloma, myelodysplastic syndrome, hairy cell leukemia).
At least 1 nodule with halo sign and no sign of airway-invasive disease; other signs allowed.
Centrilobular micronodules and/or tree-in-bud without any nodule with halo sign; other signs allowed.
Consolidations with or without halo sign, cavitated consolidation, macronodule without halo sign, and/or air crescent sign.